Dean Carmen A. Puliafito, M.D., M.B.A., lauded Eli and Edythe Broad and CIRM for their generous leadership in making the new stem
cell center possible.
Not exact matches
«Our findings provide a
possible flanking strategy to counteract the ability of melanoma
cells to re-wire their signaling networks,» said co-coresponding author Meenhard Herlyn, Caspar Wistar Professor in Melanoma Research and director of the Melanoma Research
Center at The Wistar Institute.
Now a University of Colorado Cancer
Center study published online ahead of print in the journal Oncogene offers compelling evidence explaining this failure and offering a
possible strategy for the use of retinoic acid or other retinoids against some breast cancers: Because early clinical trials are often offered to patients who have already tried other more established therapies, breast cancer
cells may have been pushed past an important tipping point that offers retinoic acid resistance.
UT Southwestern Medical
Center cancer researchers have identified a protein critical to the spread of deadly cancer
cells and determined how it works, paving the way for potential use in diagnosis and eventually
possible therapeutic drugs to halt or slow the spread of cancer.
«The aim of pathogens is to weaken their host as much as
possible, so they try to attack and take over the control
centers of the
cell, in other words the proteins with the most «friends» in the network,» explains Falter - Braun.
«Dolly the Sheep told me that nuclear reprogramming is
possible even in mammalian
cells and encouraged me to start my own project, wrote Yamanaka, who splits his time between the University of California, San Francisco, and the
Center for iPS
Cell Research and Application (CiRA) at Kyoto University in Japan, which he directs.
This study utilized 36 well - characterized melanoma
cell lines assembled by the MGH
Center for Molecular Therapeutics to test all
possible combinations of more than 100 oncology drugs, two - thirds of which are currently in clinical use.
Scheduled to be up and running in late 2016, the
center is meant to accelerate adoption of
cell therapy technologies so that the regenerative medicine industry can bring such therapies to market as fast as
possible.
At Central Kentucky Veterinary
Center, we not only provide the best animal care
possible, but also offer reproductive, stem
cell and on site cremation services.